Clin2
NCT07752511Possibly a fitNot yet recruiting

Stigma, identity, and quality of life in male hypogonadism

Hypogonadism, MaleEndocrine DiseaseHypertension

Part of Heart & circulation, Hormones & metabolism clinical trials.

This study looks at how men with low testosterone (hypogonadism) feel about stigma, their sense of self, and their quality of life. It aims to understand these experiences better so that care can be improved.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
90 people
Ages
18 years and older
Study type
Observational

Who can take part

  • You must be a man aged 18 or older.
  • You must have a confirmed diagnosis of low testosterone (below 300 ng/dL) with at least one symptom, and be under regular care at an endocrinology clinic.
  • You must be able to read and understand Turkish.
  • You must be willing to sign a consent form.
  • You must not have certain other health conditions like active psychiatric disorders, chronic inflammatory diseases, or poorly controlled endocrine issues.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07328542Not yet recruiting· Phase 4
Blood pressure monitoring study in men with low testosterone

This study examines how testosterone therapy affects blood pressure in men with low testosterone. It uses a 24-hour blood pressure monitor to track changes over time.

Birmingham, Alabama
NCT07761546Enrolling by invitation
Ai-test: microbiome nutrition for low testosterone

This study tests whether a special diet can improve symptoms of low testosterone in men. It is intended to help men with certain symptoms like a low sex drive or trouble having erections and whose blood tests show low to borderline testosterone levels.

Aydin
NCT05249634Recruiting· Phase 2
Testosterone treatment study for men with chronic kidney disease

This Phase 2 study tests whether testosterone therapy can help men with chronic kidney disease who have low testosterone and related symptoms. It looks to see if treatment is safe and beneficial, while carefully checking heart, blood, prostate, and clotting risks.

St Louis, Missouri
NCT06689085Recruiting· Phase 3
Testosterone replacement study for adolescent boys with low testosterone

This trial tests a testosterone injection (XYOSTED) to see if it's safe and effective for replacing testosterone in teenage boys who have low levels due to a known medical condition. It lasts 52 weeks, with an optional 2-year follow-up.

Los Angeles, California
NCT07278362Not yet recruiting· Phase 4
Testosterone therapy for men with low-risk prostate cancer on active surveillance

This study tests whether testosterone replacement therapy can safely improve low testosterone symptoms in men with low-risk prostate cancer who are not receiving active treatment. You may be eligible if you have confirmed low testosterone and are being monitored without intervention.

Miami, Florida
NCT04760574Recruiting
HIV status and low testosterone in men

This study looks at whether low testosterone (often called male hypogonadism) is linked to having HIV. It compares HIV-positive men with HIV-negative men to better understand what contributes to hormone problems and how common they are.

Taipei

Hear when a new Hypogonadism, Male trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.